• Mdivi-1 Reverses Apoptosis and Gut Dysbiosis in Hypoxic Lung

  2026-06-16

  This study reveals that chronic intermittent hypoxia (CIH) induces lung apoptosis by disrupting mitochondrial dynamics and gut microbiota-metabolite networks. The selective DRP1 inhibitor Mdivi-1 effectively reverses these effects, offering new insights into the interplay between the gut, metabolism, and mitochondrial apoptosis.

• TAI-1: Mechanistic Hec1 Inhibition for Translational Oncolog

  2026-06-15

  This thought-leadership article unpacks the mechanistic and translational dimensions of TAI-1, a first-in-class Hec1 inhibitor, and provides strategic guidance for researchers advancing cancer therapeutics. Integrating recent insights from genome stability research, it contextualizes TAI-1’s role in mitigating mitotic dysfunction, enhancing apoptotic cell death, and enabling synergistic therapy designs. Practical protocol parameters and a forward-looking perspective are included to empower robust, innovative cancer research.

• L-Ornithine (SKU B8919): Reliable Solutions for Metabolic As

  2026-06-15

  This article provides an evidence-driven, scenario-based guide for biomedical researchers and lab technicians seeking reproducible results in cell viability, metabolic enzyme, and CNS toxicity assays using L-Ornithine (SKU B8919). It synthesizes the latest mechanistic research and workflow optimizations, demonstrating how APExBIO’s high-purity L-Ornithine outperforms generic alternatives in reliability, solubility, and data fidelity.

• 6-FAM SE: Stable Amine-Reactive Fluorescent Labeling Reagent

  2026-06-14

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) is an amine-reactive fluorescent dye widely used for durable labeling of nucleic acids, proteins, and peptides. Its superior hydrolytic stability and high sensitivity make it a preferred choice for gene sequencing and molecular biology workflows.

• Bleomycin Sulfate in Pulmonary Fibrosis & DNA Damage Models

  2026-06-13

  Bleomycin Sulfate (Blenoxane) is a gold-standard tool for modeling chemotherapy-induced DNA damage and pulmonary fibrosis. This article delivers optimized workflows, troubleshooting insights, and translational perspectives—bridging bench protocol with pathway-driven innovation.

• Tyrothricin Peptide Antibiotic Mixture: Applied Workflows &

  2026-06-12

  Tyrothricin empowers infection research with robust, membrane-targeting antimicrobial activity across bacteria, fungi, and select viruses. This guide delivers actionable workflows, troubleshooting insights, and protocol enhancements—translating bench research into reproducible, cross-domain impact.

• Phalloidin (B7678): Technical Guidance for Actin Filament St

  2026-06-12

  Phalloidin (B7678) is used for high-affinity stabilization and visualization of filamentous actin (F-actin) in fixed or permeabilized cells. It addresses the need for robust, static cytoskeleton visualization in microscopy-based cell biology research. This compound is not suitable for live-cell imaging or experiments requiring reversible actin binding.

• ATRX Deficiency Sensitizes Glioma Cells to RTK and PDGFR Inh

  2026-06-11

  Pladevall-Morera et al. (2022) reveal that ATRX-deficient high-grade glioma cells are markedly more sensitive to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors. Their findings suggest that stratifying glioma treatments based on ATRX status could enhance therapeutic effectiveness, especially when combined with temozolomide.

• 3D Osteocyte Networks Respond to Pulsatile Fluid Flow via Cx

  2026-06-11

  This study introduces a microfluidic in vitro model that enables detailed investigation of osteocyte mechanotransduction within three-dimensional (3D) collagen networks under pulsatile unidirectional fluid flow stimuli (PUFFS). The platform reveals how dynamic flow activates connexin 43-mediated calcium signaling, providing new insights into bone mechanics and intercellular communication.

• Dacarbazine: Applied Workflows for Cancer DNA Damage Assays

  2026-06-10

  Dacarbazine remains a gold-standard antineoplastic chemotherapy drug for treatment of malignant melanoma, Hodgkin lymphoma, and sarcoma. This article distills advanced experimental protocols, data-driven troubleshooting, and new viability scoring methods, empowering researchers to maximize assay reproducibility and mechanistic insight when working with APExBIO’s Dacarbazine.

• Tyrothricin (BA1054): Reliable Antimicrobial Peptide for Res

  2026-06-10

  This article explores how Tyrothricin (SKU BA1054), a peptide antibiotic mixture from APExBIO, addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays. By grounding recommendations in validated protocols and published evidence, researchers can achieve reproducible, high-sensitivity data while mitigating contamination risks. Practical guidance and scenario-driven Q&As position Tyrothricin as a trusted tool for advanced antimicrobial research workflows.

• Palonosetron Hydrochloride in Chemotherapy-Induced Nausea Co

  2026-06-09

  The reference study by Ruhlmann and Herrstedt provides a detailed evaluation of palonosetron hydrochloride, a next-generation 5-HT3 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV). Its unique pharmacologic properties and clinical performance distinguish it from previous antiemetic agents, directly impacting patient quality of life during intensive antineoplastic chemotherapy regimens.

• Dacarbazine: Mechanism, Clinical Benchmarks, and Research Wo

  2026-06-09

  Dacarbazine is a validated antineoplastic chemotherapy drug with a defined DNA alkylation mechanism. It is primarily used for the treatment of malignant melanoma, Hodgkin lymphoma, and sarcoma. This article details its molecular action, clinical context, and laboratory integration, referencing both peer-reviewed literature and APExBIO product data.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-06-08

  This study provides a detailed molecular and epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during the COVID-19 era. The findings clarify the high prevalence and transferability of resistance genes, offering crucial insights for infection control and multidrug-resistant Gram-negative bacterial research.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-06-08

  Schwartz’s dissertation introduces a nuanced framework for assessing anti-cancer drug effects in vitro by distinguishing between proliferative arrest and cell death. This approach enhances the interpretability of results, informing the evaluation of therapies such as DNA alkylating agents for various cancer types.

483 records 10/33 page Previous Next First page 上5页 678910 下5页 Last page